CDH17 trial for gastric, colorectal and NED cancers using best in class 3rd generation CART is about to kick off. Any one want to guess when Chimeric will announce the first patient dosed for Phase 1?
- Forums
- ASX - By Stock
- Chimeric: Media Thread
CDH17 trial for gastric, colorectal and NED cancers using best...
-
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.39M |
Open | High | Low | Value | Volume |
2.1¢ | 2.1¢ | 2.1¢ | $5.446K | 259.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2129 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 737340 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2129 | 0.021 |
2 | 615100 | 0.020 |
3 | 179999 | 0.019 |
8 | 846237 | 0.018 |
4 | 535750 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 737340 | 7 |
0.023 | 250000 | 2 |
0.024 | 400000 | 3 |
0.025 | 45000 | 1 |
0.026 | 395000 | 4 |
Last trade - 15.04pm 30/07/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online